Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Keros Therapeutics Reports Recent Business Highlights And First Quarter 2020 Financial Results is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Achilles will participate in the following upcoming conferences. Additional details will be available in the Events & Presentations section of the Company’s website: Achilles is a clinical ... Read More
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
March 21, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics ... financial results for the fourth quarter and full year ending December 31, 2023, and provided an update on recent business achievements. Read More
Akari Therapeutics Reports Full-Year 2023 Financial Results And Recent Highlights
The combined entity will operate as Akari Therapeutics ... business, financial condition and results of operations. These forward-looking statements speak only as of the date of this press release ... Read More
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
March 14, 2024 /PRNewswire/ -- Akebia Therapeutics ... today reported financial results for the fourth quarter and full year ended December 31, 2023 and recent business highlights. Read More
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Recent Highlights Pipeline Programs The first poster ... in this press release, including statements regarding our future results of operations or financial condition, business strategy and ... Read More
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
BOSTON and ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase ... Read More
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
today announced its financial results for the fourth quarter and year-ended December 31, 2023, and recent business highlights. “In 2023, we made important progress on the optimization of our ... Read More
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
The Company expects that existing cash and cash equivalents will be sufficient to fund operations into the first quarter of 2025. Inhibikase Therapeutics ... This press release contains "forward ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus